Chemcrux Enterprises Balance Sheet Annual

Trade

BSE: 540395 | NSE: - | ISIN: INE298W01016 | Sector: Biotechnology & Drugs

186.10 +1.20 (0.65%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	5.11	5.91	0.11	-
Cash Equivalents	0.08	1.23	11.76	2.71
Short Term Investments	19.77	16.73	7.04	8.63
Cashand Short Term Investments	24.96	23.88	18.90	11.34
Accounts Receivable- Trade Net	15.30	13.44	18.88	3.31
Total Receivables Net	15.53	13.44	18.88	8.11
Total Inventory	8.41	14.09	11.57	7.37
Other Current Assets Total	1.40	7.44	5.47	0.67
Total Current Assets	50.29	58.84	54.83	27.49
Property/ Plant/ Equipment Total- Net	53.45	35.63	24.75	20.36
Intangibles Net	0.02	0.07	0.06	-
Long Term Investments	0.73	0.72	0.72	0.05
Note Receivable- Long Term	3.50	-	-	0.79
Other Long Term Assets Total	1.88	3.81	3.41	0.00
Total Assets	109.87	99.07	83.77	48.69
Accounts Payable	7.03	8.16	11.60	0.85
Notes Payable/ Short Term Debt	4.02	3.16	8.02	0.00
Current Portof LT Debt/ Capital Leases	0.13	0.11	0.08	-
Other Currentliabilities Total	1.77	6.21	6.46	5.41
Total Current Liabilities	12.95	17.63	26.15	6.26
Long Term Debt	21.53	12.32	0.64	0.47
Capital Lease Obligations	0.77	0.91	1.01	-
Total Long Term Debt	22.30	13.22	1.65	0.47
Total Debt	26.45	16.49	9.75	0.47
Deferred Income Tax	2.18	1.81	1.28	1.10
Other Liabilities Total	0.18	0.00	0.00	-
Total Liabilities	37.61	32.66	29.09	7.84
Common Stock Total	14.81	14.81	14.81	4.94
Retained Earnings( Accumulated Deficit)	57.45	51.60	39.87	35.92
Total Equity	72.26	66.41	54.68	40.85
Total Liabilities Shareholders' Equity	109.87	99.07	83.77	48.69
Total Common Shares Outstanding	1.48	1.48	1.48	0.16
Tangible Book Valueper Share Common Eq	48.78	44.80	36.89	248.28